Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06373744
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2024-04-16
Brief Title:
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Study Overview
Official Title:
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about the effects of metronomic chemotherapy in advanced breast cancer patients The main question it aims to answer is
How effective is metronomic chemotherapy in advanced breast cancer Specific benefit groups of metronomic chemotherapy
How effective is metronomic chemotherapy in advanced breast cancer Specific benefit groups of metronomic chemotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None